Delivery Order SPE2DB20D1100-SPE2DB24FE0N6
Award Date
9/27/24
Potential Completion Date
10/21/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Veklury (Remdesivir) 100 mg vials. The $8,851.96 firm-fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $18,725.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. It is a firm-fixed-price delivery order contract with a completion date of December 4, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The award, valued at $13,618.40, is for the delivery of 100 mg vials of the antiviral drug Veklury (remdesivir). This is a firm-fixed-price delivery order contract with an ultimate completion date of August 21, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous...
The U.S. Defense Logistics Agency (DLA) awarded a $6,803.40 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp. for the supply of 100 mg Veklury (Remdesivir) vials. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a broad range of pharmaceutical products and medical supplies for military healthcare programs. The contract has no set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,809.20 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a medication used to treat COVID-19. The contract has an ultimate completion date of August 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The contract is a firm fixed-price Delivery Order with a ceiling value of $4,754.64 and an ultimate completion date of February 13, 2025. The contract is not set aside for any specific business category....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The $3,404.60 firm-fixed price delivery order is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 and running through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of medical commodities, including critical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a medication used to treat COVID-19. The contract has a firm fixed price of $9,113.06 and a performance period extending through May 28, 2025. This contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $13,618.40 firm fixed price delivery order is for the provision of 100 mg vials of the antiviral drug Veklury (remdesivir), with a period of performance through March 7, 2024. This award is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D3103|SPE2DB24FP6V0) worth $13,618.40 for the supply of 100 mg VEKLURY (Remdesivir) vials. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 16, 2024. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions...